Dottikon Es : CHF 200 Million Proceeds for Growth from Capital Increase

MEDIA RELEASE

Dottikon, March 10, 2021

NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRA-LIA, CANADA, JAPAN, THE UNITED KINGDOM, OR THE EUROPEAN ECONOMIC AREA OR IN ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD NOT BE IN COMPLIANCE WITH APPLICABLE LAWS AND REGULATIONS.

DOTTIKON ES - CHF 200 Million Proceeds for Growth from Capital Increase

Dottikon, Switzerland, March 10, 2021 - DOTTIKON ES Group, positioned as strategic develop-ment and manufacturing partner and specialized in the area of hazardous reactions and the ex-clusive synthesis of active pharmaceutical ingredients (API) and fine chemicals, has successfully completed the capital increase resulting in net proceeds of CHF 199.5 million to finance further growth. The capital increase is aimed at financing parts of the expansion investments of around CHF 600 million during the next 7 years in new API production plants and infrastructure and the creation of over 200 new jobs in Production and Technology/Engineering at its Dottikon site (Aargau, Switzerland). Sole bookrunner and lead manager was Zürcher Kantonalbank.

Key facts on the completed capital increase

• ƒ Share capital was increased by 1'272'644 new registered shares at a nominal value of CHF 0.01 each, representing 10 percent of the previous share capital. The new number of listed registered shares will be 13'999'084

• ƒ The subscription/placement price was set at CHF 160 per new registered share

• ƒ Net proceeds from the capital increase (gross proceeds minus estimated transaction costs and fees) amount to CHF 199.5 million

• ƒ Main shareholder Markus Blocher, CEO and President of the Board of Directors, has exer-cised the announced maximum of 25 percent of his pre-emptive rights and, respecting DOTTIKON ES' free float objective, acquired additional shares through the bookbuilding process

• ƒ 82 percent of pre-emptive rights were exercised by the other existing shareholders

• ƒ DOTTIKON ES has won many new shareholders

• ƒ The free float of registered shares has risen to over 20 percent. This requirement for an SPI inclusion is therefore met

• ƒ After the capital increase, the equity ratio remains over 80 percent

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharma-ceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is spe-cialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthe-sis routes, improve selectivities, yields, and purities, and reduce waste. The versatile technology

and equipment portfolio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes.

DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development, clear and transparent data and process docu-mentation, and close customer communication.

DOTTIKON ES HOLDING AG is listed on the SIX Swiss Exchange.

Symbol: DESN

Security number: 58258171

ISIN: CH0582581713

For further information please contact

Markus Blocher, Ph.D.

CEO

Dottikon ES Holding AG

Tel [phone]

Fax [phone]

Disclaimer

This media release serves informational purposes and constitutes neither an offer to sell nor a solicitation or an advertisement to buy any shares of DOTTIKON ES HOLDING AG in any juris-diction. This media release does not constitute a prospectus within the meaning of Article 35 et seqq. of the Swiss Federal Act on Financial Services. The rights offering and the share place-ment regarding shares of DOTTIKON ES HOLDING AG have been closed and the rights exercise and placement period has expired.

This media release and the information contained therein are not being issued in the United States of America, Australia, Canada, Japan, the United Kingdom, or the European Economic Area and must not be distributed within or to such countries or via publications with a general circulation in such countries.

This media release contains forward-looking statements such as projections, forecasts, and estimates. Such forward-looking statements are subject to certain risks and uncertainties which may cause actual results, performance, or events to differ materially from those anticipated in this media release. Readers should therefore not rely on these forward-looking statements. The forward-looking statements contained in this media release are based on the views and assump-tions of DOTTIKON ES HOLDING AG as of this date and DOTTIKON ES HOLDING AG does not assume any obligation to update or revise this media release.